rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2001-1-22
|
pubmed:abstractText |
The purpose of this study was to retrospectively predict the chemotherapeutic response to paclitaxel for non-small cell lung cancer (NSCLC) using 99mTc-tetrofosmin (TF) uptake and to detect the expression of 170-kDa multidrug resistance-mediated P-glycoprotein (MDR-Pgp).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0161-5505
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
42
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
17-20
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11197970-Adult,
pubmed-meshheading:11197970-Aged,
pubmed-meshheading:11197970-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:11197970-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:11197970-Cisplatin,
pubmed-meshheading:11197970-Drug Resistance, Multiple,
pubmed-meshheading:11197970-Female,
pubmed-meshheading:11197970-Humans,
pubmed-meshheading:11197970-Lung Neoplasms,
pubmed-meshheading:11197970-Male,
pubmed-meshheading:11197970-Middle Aged,
pubmed-meshheading:11197970-Organophosphorus Compounds,
pubmed-meshheading:11197970-Organotechnetium Compounds,
pubmed-meshheading:11197970-P-Glycoprotein,
pubmed-meshheading:11197970-Paclitaxel,
pubmed-meshheading:11197970-Predictive Value of Tests,
pubmed-meshheading:11197970-Radiopharmaceuticals,
pubmed-meshheading:11197970-Retrospective Studies,
pubmed-meshheading:11197970-Thorax
|
pubmed:year |
2001
|
pubmed:articleTitle |
Paclitaxel-Based chemotherapy for non-small cell lung cancer: predicting the response with 99mTc-tetrofosmin chest imaging.
|
pubmed:affiliation |
Department of Nuclear Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|